Deep Health AI India Limited shareholders have approved the appointment of two new Non-Executive Independent Directors to its Board, strengthening its governance structure ahead of future strategic initiatives. The appointments were ratified via special resolutions during the company’s first Extra-Ordinary General Meeting (EGM) held on July 30, 2026.

The Board of Directors convened the meeting in compliance with Regulation 30 read with Part A of Schedule III of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, and Chapter V-A of the SEBI Master Circular dated January 30, 2026. The session commenced at 3:00 P.M. IST and concluded at 3:22 P.M., with e-voting remaining open for 15 minutes post-meeting to facilitate participation.

Key Resolutions Passed

The primary agenda involved the appointment of two independent directors, both requiring special resolution approval:

All resolutions were passed with the requisite majority, as confirmed by the Scrutinizer’s report submitted after the conclusion of the proceedings.

Director Profiles and Tenure

Mr. Bhupesh Swami was appointed effective July 02, 2026, for a term of two consecutive years ending July 01, 2028. He holds a Master India Boards (MIB) specialization in Export-Import (2016) from CMS, Udaipur, and brings over 20 years of experience in logistics, marketing, and import-export operations. His expertise spans supply chain management, international trade, and business development.

Mrs. Shashi Kala Dhabriya was appointed effective March 20, 2026, for a term of five consecutive years ending March 19, 2031. She holds a Master of Arts (M.A.) in History from the University of Rajasthan, completed in 1981. Neither director is inter-se related to any other Directors of the Company.

Meeting Proceedings and Participation

The EGM was conducted entirely through Video Conference (VC) and Other Audio-Visual Means (OAVM), without any physical presence of members at a common venue. The deemed venue was the company’s registered office in Udaipur, Rajasthan.

Mr. Narayan Singh Rathore, Managing Director and Chairman, chaired the meeting. All six directors, including the chairpersons of the Audit Committee, Nomination and Remuneration Committee, and Stakeholder Relationship Committee, were present. Mr. Rakesh Vishnoi, Company Secretary and Compliance Officer, was absent due to a medical emergency.

Participation was limited to remote engagement. A total of 56 public shareholders attended via video conference, while no promoter group members or proxy representatives participated. The company engaged National Securities Depositories Limited (NSDL) for remote e-voting facilities, with the voting window running from July 27, 2026, at 9:00 A.M. to July 29, 2026, at 5:00 P.M.

Governance Oversight

Mr. Ronak Jhuthawat of M/s. Ronak Jhuthawat & Co., Practicing Company Secretaries, was appointed as the Scrutinizer for the EGM by the Board in its meeting held on July 02, 2026. The Scrutinizer oversaw the vote counting process for both remote e-voting and electronic voting conducted during the EGM. Statutory documents required for inspection were made available electronically to members who requested them.

The addition of Swami and Dhabriya to the Board aligns with regulatory requirements for independent oversight and enhances the diversity of expertise within the company’s leadership team.

Deep Health AI India Limited has remitted an aggregate advance payment of ₹2.85 crore towards the proposed acquisition of land in Pune. The company entered into a Memorandum of Understanding (MoU) with M/s. Elegant Floriculture & Agrotech (India) Limited on March 06, 2026, for the purchase of a plot measuring 49,100 sq. mtr situated at Gat No. 358, Village Mouje Kashal, Taluka – Maval, District Pune. The advance was paid in 10 tranches, with the last tranche disbursed on June 06, 2026.

The proposed acquisition aims to establish a naturopathy centre and a holistic rejuvenation centre. The project will include the cultivation of medicinal plant species, with a strategic focus on organic and herb-based wellness and agro-tourism to promote preventive healthcare.

The company disclosed that the intimation regarding this transaction was inadvertently delayed due to an oversight. Upon noticing the omission, the management took immediate steps to make the necessary disclosure to the exchange.

Transaction Details

The disclosure was submitted by Narayan Singh Rathore, Managing Director of Deep Health AI India Limited.